Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil-cetuximab in first-line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy
Fatal posterior revesible leukoencephalopathy syndrome associated coma induced by bevacizumab in metastatic colorectal cancer and review of literature. Eryılmaz MK, Mutlu H, Salim DK, Musri FY, Coşkun HŞ. J Oncol Pharm Pract. 2016 Dec;22(6):806-810. Epub
Primary Tumor Resection and Survival in Patients with Stage IV Gastric Cancer. Müsri FY, Mutlu H, Karaağaç M, Eryilmaz MK, Gündüz Ş, Artaç M. J Gastric Cancer. 2016 Jun;16(2):78-84. doi: 10.5230/jgc.2016.16.2.78. Epub 2016 Jun 24.
Mean Platelet Volume as an Independent Predictive Marker for Pathologic Complete Response after Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer. Mutlu H, Eryılmaz MK, Musri FY, Gunduz S, Salim DK, Coskun HS. Asian Pac J Cancer Pre
Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme. Eryılmaz MK, Mutlu H, Yalçin Müsri F, Salim DK, Tazegül G, Coşkun HŞ. J Oncol Pharm Pract. 2017 Jul;23(5):392-395. doi: 10.1177/1078155216643858. Epub 2
The Neutrophil to Lymphocyte Ratio is an Independent Prognostic Factor in Patients with Metastatic Gastric Cancer. Musri FY, Mutlu H, Eryilmaz MK, Salim DK, Gunduz S, Coskun HS. Asian Pac J Cancer Prev. 2016;17(3):1309-12.
Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease. Colak Y, Bozbey G, Erim T, Caklili OT, Ulasoglu C, Senates E, Mutlu HH, Mesci B, Doğan MS, Tasan G, Enc FY, Tuncer I. J Neurogastroen
Gastrointestinal stromal tumor and isolated anterior tibial muscle metastasis as first recurrence. Mutlu H, Balkarlı H, Musri FY, Salim DK, Eryılmaz MK, Ünal B, Coşkun HŞ. J Cancer Res Ther. 2015 Oct-Dec;11(4):1037. doi: 10.4103/0973-1482.151862.
Experience of bevacizumab in a patient with colorectal cancer after renal transplantation. Müsri FY, Mutlu H, Eryılmaz MK, Salim DK, Coşkun HŞ. J Cancer Res Ther. 2015 Oct-Dec;11(4):1018-20. doi: 10.4103/0973-1482.168996.
Protective Effects of Curcumin on Intestinal Damage in Cholestatic Rats. Kanter M, Takir M, Mutlu HH, Kanter B, Kostek O, Toprak AE. J Invest Surg. 2016 Jun;29(3):128-36. doi: 10.3109/08941939.2015.1088604. Epub 2015 Dec 18.
Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab. Gündüz S, Göksu SS, Arslan D, Tatli AM, Uysal M, Gündüz UR, Sevinç MM, Coşkun HS, Bozcuk H, Mutlu H,
Is there any relation between PET-CT SUVmax value and prognostic factors in locally advanced breast cancer? Tural D, Kivrak Salim D, Mutlu H, Erkilic M, Gunduz S, Karakurt M, Musri F, Tuna S, Boz A, Aydin F, Karayalcin B, Bozcuk H, Senol Coskun H. J BUON.
The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus. Karagoz H, Erden A, Ozer O, Esmeray K, Cetinkaya A, Avci D, Karahan S, Basak M, Bulut K, Mutlu H, Simsek Y. Ther Clin Risk Manag. 2015 Oct 19;11:1613-7.
Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer. Salim DK, Mutlu H, Eryilmaz MK, Salim O, Musri FY, Tural D, Gündüz Ş, Coşkun HŞ. Mol Clin Oncol. 2015 Jul;3(4):
Metronomic oral chemotherapy with old agents in patients with heavily treated metastatic breast cancer. Mutlu H, Musri FY, Artaç M, Kargi A, Özdogan M, Bozcuk H. J Cancer Res Ther. 2015 Apr-Jun;11(2):287-90. doi: 10.4103/0973-1482.154008.
Prognostic factors in clinical stage T4N2 locally advanced non-small cell lung cancer. Arslan D, Tural D, Koca T, Tastekin D, Kaymak Cerkesli A, Basaran H, Gunduz S, Murat Tatli A, Sezgin Goksu S, Uysal M, Kargi A, Kargi B, Koral L, Ibrahim Bassorgun C, U
Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer. Gunduz S, Mutlu H, Tural D, Yıldız Ö, Uysal M, Coskun HS, Bozcuk H. Asia Pac J Clin Oncol. 2015 Dec;11(4):288-92. doi: 10.1111/ajco.12358. Epub 2015 Apr 14.
The Optimal Treatment Modality in Patients with T4N2M0 Non-Small Cell Lung Cancer: The Best Choice May Be Definitive Chemoradiotherapy Followed by Consolidation Chemotherapy. Mutlu H, Arslan D, Gündüz S, Tural D, Büyükçelik A, Cihan YB, Aslan T, Bozcuk H,
Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy. Eryılmaz MK, Mutlu H, Salim DK, Musri FY, Tural D, Başsorgun I, Coşkun HŞ. J Oncol Pharm Pract. 2016 Jun;22(3):533-6. doi: 10.1177/1078155215572930. Epub 2015 Feb 17.
Sorafenib-induced severe urticaria in a patient with hepatocellular cancer. Musri FY, Mutlu H, Kıvrak Salim D, Karakurt Eryılmaz M, Ünal B, Tural D, Şenol Coşkun H. J Oncol Pharm Pract. 2016 Apr;22(2):350-3. doi: 10.1177/1078155214565126. Epub 2015 Jan 6.
Stewart-Treves Syndrome after Bilateral Mastectomy and Radiotherapy for Breast Carcinoma: Case Report. Taşdemir A, Karaman H, Ünal D, Mutlu H. J Breast Health. 2015 Apr 1;11(2):92-94. doi: 10.5152/tjbh.2015.1604. eCollection 2015 Apr.